Cardiorespiratory function in stable methadone maintenance treatment (MMT) patients

Addiction Biology

Volumn 9, Issue 3-4, 2004, Pages 247-253

  Teichtahl, Harry ^a,b   Wang, David ^a,b   Cunnington, David ^a,b   Kronborg, Ian ^a   Goodman, Cathy ^a   Prodromidis, Andy ^a   Drummer, Olaf ^c  

^a WESTERN HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c VICTORIAN INSTITUTE OF FORENSIC MEDICINE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; CANNABIS; DIAMORPHINE; ILLICIT DRUG; METHADONE; OPIATE; TETRAHYDROCANNABINOL;

ADULT; ARTICLE; CANNABIS ADDICTION; CIGARETTE SMOKING; CLINICAL ARTICLE; DRUG BLOOD LEVEL; ELECTROCARDIOGRAPHY; FEMALE; FORCED EXPIRATORY VOLUME; GAS CHROMATOGRAPHY; HEROIN DEPENDENCE; HUMAN; LUNG FUNCTION; MALE; MASS SPECTROMETRY; METHADONE TREATMENT; MULTIPLE DRUG ABUSE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; THORAX RADIOGRAPHY; TOBACCO;

ADOLESCENT; ADULT; BREATH TESTS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FORCED EXPIRATORY VOLUME; HEROIN DEPENDENCE; HUMANS; MALE; MARIJUANA SMOKING; METHADONE; MIDDLE AGED; OXYGEN; POLYSOMNOGRAPHY; SLEEP APNEA, CENTRAL; SMOKING; SUBSTANCE ABUSE DETECTION; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 8544277234     PISSN: 13556215     EISSN: None     Source Type: Journal    
DOI: 10.1080/13556210412331292578     Document Type: Article

References (38)

1. Australian Institute of Health and Welfare. 1998 National Drug Strategy House hold Survey: first results. Canberra: AIHW; 1999.
2. NIH Consensus Conference. Effective medical treatment of opiate addiction. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. JAMA 1998;280:1936-43.
3. Ward J, Mattick RP, Hall W. Methadone maintainance treatment and other opioid replacement therapies. Amsterdam: Harwood Academic; 1998.
4. Commonwealth of Australia Department of Health and Aged Care, unpublished data; 2000.
5. Miller A, Taub H, Spinak A, Pilipski M, Brown LK. Lung function in former intravenous drug abusers: the effect of ubiquitous cigarette smoking. Am J Med 1991;90:678-84.
6. Joseph H, Stancliff S, Langrod J. Methadone maintenance treatment (MMT): a review of historical and clinical issues. Mount Sinai J Med 2000;67:347-64.
7. Cunnington D, Teichtahl H, Hunt JM, Dow C, Valentine R. Necrotizing pulmonary granulomata in a marijuana smoker. Chest 2000;117:1511-15.
8. Goldstein A, Herrera J. Heroin addicts and methadone treatment in Albuquerque: a 22-year follow-up. Drug Alcohol Depend 1995;40:139-50.
9. Dressier FA, Roberts WC. Modes of death and types of cardiac diseases in opiate addicts: analysis of 168 necropsy cases. Am J Cardiol 1989;64:909-20.
10. DeWitt DE, Paauw DS. Endocarditis in injection drug users. Am Fam Physician 1996;53:2045-9.
11. Broyles LM, Korniewicz DM. The opiate-dependent patient with endocarditis: addressing pain and substance abuse withdrawal. AACN Clin Issues 2002;13:431-51.
12. Taylor DR, Hall W. Respiratory health effects of cannabis: Position Statement of the Thoracic Society of Australia and New Zealand. Intern Med J 2003;33:310-13.
13. Camargo G, Colp C. Pulmonary function studies in ex-heroin users. Chest 1975;67:331-4.
14. Overland ES, Nolan AJ, Hopewell PC. Alteration of pulmonary function in intravenous drug abusers. Prevalence, severity, and characterization of gas exchange abnormalities. Am J Med 1980;68:231-7.
15. Lipski J, Stimmel B, Donoso E. The effect of heroin and multiple drug abuse on the electrocardiogram. Am Heart J 1973;86:663-8.
16. Teichtahl H, Prodromidis A, Miller B, Cherry G, Kronborg I. Sleep-disordered breathing in stable methadone programme patients: a pilot study. Addiction 2001;96:395-403.
17. American Thoracic Society. Standardization of spirometry, 1994 update. American Thoracic Society. Am J Respir Crit Care Med 1995;152:1107-36.
18. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981;123:659-64.
19. Roca J, Rodriguez-Roisin R, Cobo E, Burgos F, Perez J, Clausen JL. Single-breath carbon monoxide diffusing capacity prediction equations from a Mediterranean population. Am Rev Respir Dis 1990;141:1026-32.
20. Hughes JMB, Pride NB. Lung function tests: physiological principles and clinical applications. London: W. B. Saunders; 1999.
21. Read DJ. A clinical method for assessing the ventilatory response to carbon dioxide. Aust Ann Med 1967;16:20-32.
22. Rebuck AS, Campbell EJ. A clinical method for assessing the ventilatory response to hypoxia. Am Rev Respir Dis 1974;109:345-50.
23. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
24. Chu MH, Drummer OH. Determination of delta9-THC in whole blood using gas chromatography-mass spectrometry. J Anal Toxicol 2002;26:575-81.
25. Sansores RH, Pare PD, Abboud RT. Acute effect of cigarette smoking on the carbon monoxide diffusing capacity of the lung. Am Rev Respir Dis 1992;146:951-8.
26. Wu TC, Tashkin DP, Djahed B, Rose JE. Pulmonary hazards of smoking marijuana as compared with tobacco. N Engl J Med 1988;318:347-51.
27. Miller A, Thornton JC, Warshaw R, Andersen H, Teirstein AS, Selikoff IJ. Single breath diffusing capacity in a representative sample of the population of Michigan, a large industrial state. Predicted values, lower limits of normal, and frequencies of abnormality by smoking history. Am Rev Respir Dis 1983;127:270-7.
28. Van Ganse WF, Ferris BG Jr, Cotes JE. Cigarette smoking and pulmonary diffusing capacity (Transfer factor). Am Rev Respir Dis 1972;105:30-41.
29. Tockman M, Menkes H, Cohen B, et al. A comparison of pulmonary function in male smokers and nonsmokers. Am Rev Respir Dis 1976;114:711-22.
30. Douglas FG, Kafilmout KJ, Patt NL. Foreign particle embolism in drug addicts: respiratory pathophysiology. Ann Intern Med 1971;75:865-80.
31. Karliner JS, Steinberg AD, Williams MH Jr. Lung function after pulmonary edema associated with heroin overdose. Arch Intern Med 1969;124:350-3.
32. Rosen MJ, Tow TW, Teirstein AS, Chuang MT, Marchevsky A, Bottone EJ. Diagnosis of pulmonary complications of the acquired immune deficiency syndrome. Thorax 1985;40:571-5.
33. Santiago TV, Pugliese AC, Edelman NH. Control of breathing during methadone addiction. Am J Med 1977;62:347-54.
34. Bradley TD. Crossing the threshold: implications for central sleep apnea. Am J Respir Crit Care Med 2002;165:1203-4.
35. Naughton MT. Pathophysiology and treatment of Cheyne-Stokes respiration. Thorax 1998;53:514-8.
36. Andy JJ, Sheikh MU, Ali N, et al. Echocardiographic observations in opiate addicts with active infective endocarditis. Frequency of involvement of the various valves and comparison of echocardiographic features of right- and left-sided cardiac valve endocarditis. Am J Cardiol 1977;40:17-23.
37. Glauser FL, Downie RL, Smith WR. Electrocardiographic abnormalities in acute heroin overdosage. Bull Narc 1977;29:85-9.
38. Duberstein JL, Kaufman DM. A clinical study of an epidemic of heroin intoxication and heroin-induced pulmonary edema. Am J Med 1971;51:704-14.